MYD88 and acute respiratory distress syndrome: These results suggest that Fucoxanthin inhibits the TLR4/MyD88-mediated inflammatory signaling pathway by directly targeting TLR4, which suppresses LPS-induced inflammatory responses, and Fucoxanthin may be a candidate compound for the treatment of ALI.